SLC18A2: Synaptic vesicular amine transporter
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Electrogenic antiporter that exchanges one cationic monoamine with two intravesicular protons across the membrane of secretory and synaptic vesicles.
- Drugs that act on it: 8
- With a US drug page: 6
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Benzphetamine | Approved | Synaptic vesicular amine transporter inhibitor | Inhibitor | — |
| Deserpidine | Approved | Synaptic vesicular amine transporter inhibitor | Inhibitor | — |
| Rescinnamine | Approved | Synaptic vesicular amine transporter inhibitor | Inhibitor | — |
| Reserpine | Approved | Synaptic vesicular amine transporter inhibitor | Inhibitor | Withdrawn |
| Tetrabenazine | Approved | Synaptic vesicular amine transporter inhibitor | Inhibitor | Boxed warning |
| Valbenazine | Approved | Synaptic vesicular amine transporter inhibitor | Inhibitor | Boxed warning |
| Dextroamphetamine | — | Synaptic vesicular amine transporter inhibitor | Inhibitor | Boxed warning |
| Lisdexamfetamine | — | Synaptic vesicular amine transporter inhibitor | Inhibitor | Boxed warning |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Brain dopamine-serotonin vesicular transport disease
- 0.71
- Parkinsonism-dystonia, infantile
- 0.67
- Movement disorder
- 0.58
- Choreatic disease
- 0.57
- Hypertensive disorder
- 0.56
- Alzheimer disease
- 0.51
- Obesity disorder
- 0.51
- Narcolepsy-cataplexy syndrome
- 0.50
- Drug dependence
- 0.46
- Arteriosclerosis
- 0.46
Drugs and mechanisms are from ChEMBL CHEMBL1893 (CC BY-SA 3.0). Gene name, function (UniProt Q05940, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets